Which hedge funds own TRDA? ENTRADA THERAPEUTICS INC, Q2 2026 13F holders
8 of the hedge funds tracked by WhaleCreep disclosed a position in TRDA (ENTRADA THERAPEUTICS INC) in their Q2 2026 13F filings, worth $12.5m in total. The largest holder by portfolio weight is Moore Capital Management at 0.0% of its book. 1 manager opened a new position this quarter: Point72 Asset Management LP. 1 exited: Marshall Wace.
8tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold TRDA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Moore Capital Management | Q2 2026 | 0.0% | $772.8k | 105,000 | 0% | held |
| Millennium Management | Q2 2026 | 0.0% | $5.6m | 763,959 | 47% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $250.0k | 33,969 | 29% | added |
| Woodline Partners | Q2 2026 | 0.0% | $1.1m | 145,600 | -33% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.4m | 191,000 | -5% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $2.9m | 394,323 | 83% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $209.8k | 28,500 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $238.4k | 32,397 | -59% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace | 0.0% | $678.5k |
How has hedge fund ownership of TRDA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $12.5m |
| Q1 2026 | 8 | $17.9m |
| Q4 2025 | 4 | $5.4m |
| Q3 2025 | 2 | $4.1m |
| Q2 2025 | 2 | $3.3m |
| Q1 2025 | 2 | $3.9m |
| Q4 2024 | 2 | $4.7m |
| Q3 2024 | 2 | $3.2m |
| Q2 2024 | 2 | $2.1m |
| Q1 2024 | 1 | $1.5m |
| Q4 2023 | 1 | $1.6m |
| Q3 2023 | 1 | $1.7m |
| Q2 2023 | 1 | $1.6m |
| Q1 2023 | 2 | $1.6m |
| Q4 2022 | 1 | $1.4m |
| Q3 2022 | 1 | $1.7m |
Counts every tracked manager that disclosed TRDA in that quarter's filing, including managers that have since stopped filing.